ARWR

NASDAQStock

Arrowhead Pharmaceuticals, Inc.

$55.44-2.72 (-4.68%)

52-Week Range

$9.99

$73.00

Key Stats

Market Cap

7.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.30

Volume

2.5M

Avg Volume

2.4M

Performance

-10.63%

-19.63%

+91.87%

YTD

-18.85%

+265.03%

+107.12%

-23.44%

Price Chart

ETF Exposure

ARWR is held by 133 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	19,788	$1.2M	$12.10B	0.03%
AVUS	Avantis U.S. Equity ETF	0.01%	15,606	$924K	$11.08B	0.15%
VT	Vanguard Total World Stock ETF	0.01%	97,342	$6.7M	$80.60B	0.06%
ITDG	iShares LifePath Target Date 2055 ETF	0.01%	71	$4K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.01%	47	$3K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.01%	36	$2K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.01%	16	$936	$9.5M	0.12%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	86	$5K	$59.0M	0.11%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	3,035	$180K	$2.84B	0.19%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	36	$2K	$33.4M	0.34%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	72	$4K	$64.1M	0.11%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	364	$22K	$618.9M	0.12%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	915	$54K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	2,644	$157K	$3.28B	0.20%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	5	$271	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	25	$1K	$30.3M	0.32%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	21	$1K	$26.4M	0.50%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	63	$4K	$81.7M	0.11%
AFTY	Pacer CSOP FTSE China A50 ETF	0.00%	18,316	$396K	$4.3M	0.70%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	299	$18K	$733.2M	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	73	$4K	$694.1M	0.23%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	3,740	$221K	$41.36B	0.17%
DFUS	Dimensional - US Equity Market ETF	0.00%	2,768	$164K	$18.80B	0.09%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	4	$220	$9.0M	0.30%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	11	$661	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	37	$2K	$81.5M	0.10%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	178	$11K	$2.68B	0.14%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	600	$36K	$10.55B	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,123	$72K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,123	$72K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,123	$72K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,123	$72K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,123	$72K	$3.7M	0.70%

PreviousPage 3 of 3

About ARWR ETF Exposure

Arrowhead Pharmaceuticals, Inc. (ARWR) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.8B, ARWR is a widely held institutional stock. The stock currently trades at $55.44. Investors can gain exposure to ARWR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARWR, sorted by portfolio weight.